Panchayat 365
Technology | 03 Feb 2026

Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
  • Deficiencies limited to packaging and administration
  • Company believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026
  • Remains well-capitalized … [+17881 chars]
पूरा लेख पढ़ें →